• Users Online: 596
  • Print this page
  • Email this page
CONSENSUS REPORT
Year : 2020  |  Volume : 22  |  Issue : 2  |  Page : 73-78

Management of bleeding risk before pleural procedures: A consensus statement of Turkish respiratory society – Pleura study group


1 Department of Chest Diseases, Gazi University Medical Faculty, Ankara, Turkey
2 Department of Chest Diseases, Hacettepe University Medical Faculty, Ankara, Turkey
3 Department of Chest Diseases, Izmir Dr. Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Health Sciences University, İzmir, Turkey
4 Department of Chest Diseases, Ufuk University Medical Faculty, Ankara, Turkey
5 Clinic of Thoracic Surgery, University of Heath Sciences Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey
6 Department of Chest Diseases, Ege University Medical Faculty, İzmir, Turkey
7 Eskisehir Osmangazi University Lung and Pleural Cancers Research and Clinical Center, Eskisehir, Turkey

Correspondence Address:
Dr. Nilgun Yilmaz Demirci
Department of Chest Diseases, Gazi University Medical Faculty, Ankara
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ejop.ejop_28_20

Rights and Permissions

Pleural effusion is a common clinical entity. Pleural procedures performed for the diagnosis and management of pleural effusions may increase the risk of bleeding, especially in patients with coagulopathies and comorbidities and those in need for antithrombotic drugs. Current literature provides sparse, low level of evidence, which is insufficient for safe implementation of pleural procedures among these patients. Thoracentesis, pleural biopsy (closed or percutaneous), catheter or chest tube drainage, and thoracoscopy are the main pleural procedures performed in these patients. Considering the bleeding risk associated with a specific pleural procedure, the risk is low for thoracentesis, moderate for insertion or removal of the chest tube or tunneled catheter, and moderate high for pleural biopsies and thoracoscopy. The current statement is prepared mainly for the pulmonologists and intended to provide recommendations to reduce the risk of bleeding following pleural procedures. The management of bleeding complication is out of the scope of this statement.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed182    
    Printed6    
    Emailed0    
    PDF Downloaded72    
    Comments [Add]    

Recommend this journal